Research Focus

Former Employee. Graduate Staff; Fellow

Recent additions – View all

1. Pharmacokinetics and safety of ILX23-7553, a non-calcemic-vitamin D 3 analogue, in a phase I study of patients with advanced malignancies

   Journal Article

   Wieder, R.; Novick, S. C.; Hollis, B. W.; Bryan, M.; Chanel, S. M.; Owusu, K.; Camastra, D.; Saunders, T.; Pliner, L.; Harrison, J.; more...
   Investigational New Drugs (2003)

   Fulltext@MSK | Save
2. Phase I trial of the proteasome inhibitor PS-341 in patients with refractory hematologic malignancies

   Journal Article

   Orlowski, R. Z.; Stinchcombe, T. E.; Mitchell, B. S.; Shea, T. C.; Baldwin, A. S.; Stahl, S.; Adams, J.; Esseltine, D. L.; Elliott, P. J.; Pien, C. S.; more...
   Journal of Clinical Oncology (2002)

   Fulltext@MSK | Save
3. Arsenic trioxide (As(2)O(3)): A dose-ranging and clinical pharmacologic study in patients with advanced hematologic cancers

   Meeting Abstract

   Soignet, S. L.; Novick, S.; Bienvenu, B.; Chanel, S.; Ho, R.; Spriggs, D.; Ellison, R.; Warrell, R. P. Jr
   Proceedings of the American Association for Cancer Research Annual Meeting (2000)

   Fulltext@MSK | Save